Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
Author:
Funder
Korean Endocrine Society of EnM
Publisher
Korean Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism
Link
http://www.e-dmj.org/upload/pdf/dmj-2020-0206.pdf
Reference35 articles.
1. Clinical Characteristics of Coronavirus Disease 2019 in China
2. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
3. Encountering COVID-19 as Endocrinologists
4. The Outbreak of COVID-19 and Diabetes in Korea: “We Will Find a Way as We Have Always Done”
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study;Biomedicines;2023-08-18
2. ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases;Inflammation Research;2023-08
3. COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study;Microorganisms;2023-05-27
4. ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAS dysregulation in severe cases;2023-05-24
5. Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis;Diabetologia;2023-05-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3